Steven George Hughes, Chief Medical Officer at Avidity Biosciences, Inc. (RNA), sold 4,895 shares at $72.45 ($355K) on 2026-01-21, disclosed to the SEC on 2026-01-23.
Scheduled sale ($355k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.45 | 2,017 | $146K | 41.2% |
| 2 | $72.45 | 2,878 | $209K | 58.8% |
| Total | $72.45 avg | 4,895 | $355K | 100% |
| Filing → |
| RNA | SELL | 2025-09-23 | $179K | — | Filing → |
| RNA | SELL | 2025-09-17 | $140K | — | Filing → |
| RNA | SELL | 2025-08-22 | $205K | — | Filing → |